Radioimmunoassay, Thyroid-Stimulating Hormone
Adverse-event figures are drawn from the U.S. Food & Drug Administration (FDA) MAUDE database, refreshed March 2026, see our methodology.
OpenFDA device adverse-event casebook.
FDA Class II (moderate risk, special controls required), regulated under 21 CFR §862.1690 (Clinical Chemistry panel).
FDA MAUDE casebook
openFDA event book Radioimmunoassay LIGHT-BOOK · MAUDE
#426 of 1000 · 2,771 reports · 1994–2026
- BOOK 2,771 reports
- RANK #426 of 1000
- DEATH 0 death-typed
- INJ 71 injury-typed
- MALF 2,688 malfunction
- SPAN 1994–2026
- PEAK 2018: 249
- PHOTO Separator
Nearest event-volume peer: Separator, Automated, Blood Cell And Plasma, Therapeutic (2 report gap)
Radioimmunoassay, Thyroid-Stimulating Hormone sits #426 of 1000 among tracked device types with 2,771 MAUDE reports spanning 1994–2026. Rank counts report volume, not confirmed device fault. Event_type Death / Injury / Malfunction are one code per report — not the same population as patient-outcome rows ( methodology). Read with this device → · Lead manufacturer → · Similar-volume device →
Malfunction reports run above the device-type norm
Radioimmunoassay carries 97.0% MALFUNCTION-coded reports, 32.2pp above the 1,000-device-type mean, the widest gap of its three event codes. Codes are report labels, not adjudicated causation.
- DEATH 0.0% corpus 1.5% · below corpus mean (-1.5 pp)
- INJ 2.6% corpus 30.3% · below corpus mean (-27.7 pp)
- MALF 97.0% corpus 64.8% · above corpus mean (+32.2 pp)
Lead product-problem code Low Test Results is 40% of coded problems · Lead manufacturer ROCHE DIAGNOSTICS accounts for 55% of manufacturer-tagged reports · Top event location is 48% of location-tagged rows .
Radioimmunoassay in the event-volume neighbourhood
FDA MAUDE report totals among this device type and nearest nationwide peers
- Catheter And…
Catheter And Tip, Suction
2,781 reports
- Radioimmunoas… (this)
Radioimmunoassay, Thyroid-Stimulating Hormone
2,771 reports
- Separator
Separator, Automated, Blood Cell And Plasma, Therapeutic
2,769 reports
- Prosthesis
Prosthesis, Penile
2,754 reports
- Real Time Nuc…
Real Time Nucleic Acid Amplification System
2,746 reports
- System
System, Endovascular Graft, Arteriovenous (Av) Dialysis Access Circuit Stenosis Treatment
2,731 reports
What this shows Radioimmunoassay, Thyroid-Stimulating Hormone carries 2,771 MAUDE reports, ranked #426 of 1000.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Top Product Problems
Yearly Trend
Reports fell to 104 in 2025, down from an average of 166 in the two years before.
Related Entities for Radioimmunoassay, Thyroid-Stimulating Hormone
Top Manufacturers
Event Locations
Nationwide devices with a comparable report-volume footprint
Radioimmunoassay carries zero death-typed MAUDE reports, so the peer set below compares report volume only; both axes are floored at ≥100 reports so the neighborhood stays in the advertised mass.
Similar report volume
Nearest other device types by FDA MAUDE report count (2,771 here).
Similar death-typed counts
Nearest other device types by death-typed report count (0 here), distinct from the volume row.
Read our methodology - how this data is sourced, computed, and verified.
Disclaimer: MAUDE figures for Radioimmunoassay are informational only and are not clinical advice. Report codes do not prove device causation. Consult a qualified clinician before acting on this data.
Every figure on PlainHospital is rendered directly from federal source data, no number is typed in by an editor. Event-type mix on this page is computed from FDA MAUDE codes for Radioimmunoassay; corpus means use device types with ≥100 reports. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.